Algorithms are finding hidden human connections in end-of-life care

When patients and family members discuss end-of-life matters with professional caregivers, the silences between words can be as telling as the words themselves.

To better understand these communications, a palliative care specialist at the University of Vermont is leading an effort to categorize and code such silences. From these inputs, the team is training AI algorithms to identify meaningful moments of emotional connection that can inform palliative care going forward.

The work of Robert Gramling, MD, and his brother David, a linguistics professor at the University of Arizona, gets a thorough going-over in a long-form piece published by Mosaic.

One fruit of the Gramlings’ work is the Vermont Conversation Lab, the reader learns, which has amassed a database of more than 12,000 minutes and 1.2 million words of conversation involving 231 patients.

This database is set up to help find features of those conversations “that make patients and family members feel heard and understood,” explains article author Michael Erard, PhD, a language expert.

The piece also looks at similar work going on elsewhere. Among the sources Erard spoke with is the daughter of a terminal cancer patient whose diagnosis had come as a shock.

“I ask[ed] Judy’s daughter Kate what she thinks of using artificial intelligence to enrich human connections,” Erard writes.

Judy replied: “I wouldn’t worry about the technology. The more technology, the more sacred the conversation becomes.”

Read the whole thing:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.